Rayzon was established in 2019 and has operations in Changsha, Beijing, Shanghai, Hong Kong, Germany, etc. We embrace the prin ciples of patients first, professionalism and innovation. We are an international ophthalmic health technology company that incorpo rates research and development, manufacture, commercialization, and service.
Rayzon closely collaborates with healthcare providers and research institutions worldwide, striving to develop products that better meet the needs of doctors and patients, and benefit everyone in the world. Through in house research and development, investments, we have established a rich product line collaborations for optometry and ophthalmology.
We believe it is patient needs that drive the development of medical products enterprises. Only with insights of patient needs can we carry out constant and successful innovation.
We are a medical technology enterprise integrates research and development, manufacture and commercialization. We believe the achievement of each strategic goal comes from diligent thinking and action, therefore we advocate a self-motivated culture.
We listen to our patients, physicians, partners, with passion, and provide them with accessible solutions. We respect and care for each employee’s physical and mental health, quality of life and career development.
We strive to be industry leader, dare to enter the unknown, and have the passion to consistently exceed ex-pectations. We focus on every detail of our products, every interaction with patients and doctors, and strive to challenge higher goals.
Rayzon Medical was established.
Established domestic R&D center
Established domestic manufac-ture base
Established material laboratory
Incorporated raw material enter-prise in Europe
The self-developed orthokera-tology lens entered clinical trial, accelerating business presence in domestic market.
The self-developed scleral lens started
Continued to strengthen pipe-line through
Launched Oculista defocus spec-tacle lenses.
Incorporated ophthalmic knives
Launched Oculista rigid gas permeablecontact lenses for orthokeratology.
Launched Oculista rigid scleral contactlens
2019
2020
2021
2022
2023
2024
2025
Facing the international community, we aim to be the benchmark for'quality'and'service' in the ophthalmology industry. We extend our service scope to the pre‑diagnosis and post‑surgery stages, disseminate knowledge about ophthalmic diseases and eye care, and dispel public fears and misconceptions regarding such conditions.
Long‑term service cycle
We extend our service scope to the pre‑diagnosis and post‑surgery stages.
High‑quality service
Facing the international community, we aim to be the benchmark for quality and service in the ophthalmology industry.
Popular science on disease prevention
We disseminate knowledge about ophthalmic diseases and eye care, and dispel public fears and misconceptions regarding such conditions.
To Public
To Patients And Eyecare Professionals
To Employees
To Government
Building 3, No. 99 Quanshui Road, Meixihu Street, Yuelu District, Changsha City, Hunan Province
